TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ANVS

Annovis Bio Inc

Healthcare · Biotechnology

1.30$ -5.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ANVS
Line item 2010 2011 2012 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -100.0% – -100.0% – – – – – – – –
– -100.0% – – – – – – – – – –
– -100.0% – – – – – – – – – –
– – – – -59.2% +595.5% +293.4% +177.6% +94.8% +134.9% -48.5% +26.1%
– -19.6% +0.0% -79.0% +47.2% +37.7% +332.4% +68.9% +48.5% -30.6% +7.3% -33.1%
– -100.0% – -65.2% +4.6% +124.9% +313.5% +118.9% +75.5% +76.5% -40.7% +11.2%
– – – – – – – – – – – –
– – – – -21.4% +62,019,597.0% +15.4% -100.0% +1,270.2% – – –
– – – – – – – – – – – –
– -100.0% – – – – – – – – – –
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?